Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
NEEDHAM, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.26 | -13.6069114471 | 9.26 | 9.4 | 7.95 | 1133806 | 8.54252036 | CS |
4 | 0.895 | 12.5967628431 | 7.105 | 10.38 | 5.9 | 3112740 | 8.26440823 | CS |
12 | 2 | 33.3333333333 | 6 | 14.6 | 3.785 | 3867376 | 7.8454254 | CS |
26 | 1.8 | 29.0322580645 | 6.2 | 14.6 | 3.785 | 1880785 | 7.731516 | CS |
52 | 6.7 | 515.384615385 | 1.3 | 14.6 | 1.16 | 2439437 | 7.12659197 | CS |
156 | 1.26 | 18.6943620178 | 6.74 | 14.6 | 0.66 | 874119 | 6.71105407 | CS |
260 | 0 | 0 | 8 | 14.78 | 0.66 | 768215 | 6.74798986 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales